TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from IP Group plc ( (GB:IPO) ).
IP Group plc announced that its portfolio company, Artios Pharma Ltd, has completed an oversubscribed $115 million Series D financing round. The funds will be used to expand clinical trials for Artios’ lead program, alnodesertib, in pancreatic and colorectal cancer, and to initiate a Phase 2 trial for ART6043 in breast cancer. This financing round, co-led by SV Health Investors and RA Capital Management, underscores Artios’ potential in the DNA damage response field, aiming to deliver first-in-class cancer treatments and strengthen its market position.
The most recent analyst rating on (GB:IPO) stock is a Buy with a £103.00 price target. To see the full list of analyst forecasts on IP Group plc stock, see the GB:IPO Stock Forecast page.
Spark’s Take on GB:IPO Stock
According to Spark, TipRanks’ AI Analyst, GB:IPO is a Neutral.
IP Group plc’s stock score is primarily constrained by weak financial performance, characterized by persistent losses and negative cash flows, impacting profitability and stability. Technical analysis provides some short-term support, but the long-term outlook remains bearish. Valuation metrics are unattractive due to negative earnings, although the share buyback program offers a positive element, reflecting management’s proactive approach to enhancing shareholder value.
To see Spark’s full report on GB:IPO stock, click here.
More about IP Group plc
IP Group plc is a company that invests in breakthrough science and innovation companies, focusing on those with the potential to create a better future. Their portfolio includes companies in various sectors, with a particular emphasis on life sciences and technology.
Average Trading Volume: 3,305,448
Technical Sentiment Signal: Hold
Current Market Cap: £547.6M
For a thorough assessment of IPO stock, go to TipRanks’ Stock Analysis page.